Health2 hours ago
Dyne Therapeutics Advances Duchenne Drug Towards Approval
Dyne Therapeutics announced on October 16, 2023, that its experimental drug for **Duchenne muscular dystrophy** (DMD) has successfully met the primary endpoint in a late-stage clinical...